Integer Holdings Corporation
ITGRMedical Devices
$126.52−0.02%As of Oct 29vs prior close
- Market cap
- $4.3B
- P/E (TTM)
- 41.6×
- P/E (FY1)
- 20.5×
- From 52W high
- −0.18%
- EPS (LTM)
- $3.00
- Revenue (LTM)
- $1.8B
- Net margin
- 5.68%
- Dividend yield
- 0.00%
Nomior Score
74
Steady ProfileSpeculativeTop 5% of the scored universe
Growth44
Quality59
Value62
Momentum99
Resilience61
Growth
+6.24%revenue a year over 9 fiscal years
FY16 $1.1BLTM $1.8B
Connections
Revenue to profitQ3 FY26
3% of revenue became net profit, down 5 pts on a year.
Latest resultsThird Quarter 2026
- Adjusted EPS
- $1.34
Sales and profit declined year over year in the quarter, with Cardio & Vascular and Other Markets lower and Cardiac Rhythm Management & Neuromodulation higher. Results were pressured by lower operating income and higher restructuring, ERP and transaction-related costs. The company is not providing a financial outlook because of its pending acquisition by an affiliate of investment funds managed by KKR.
Who owns it
2funds